Brain Zinc Deficiency Exacerbates Cognitive Decline in the R6/1 Model of Huntington’s Disease

There is currently no disease-modifying treatment for Huntington’s disease (HD), which is characterized by chorea motor impairment and cognitive decline. The zinc ionophore, PBT2, was previously shown to improve the phenotype of a HD mouse model and reported efficacy in certain cognitive tests in a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurotherapeutics
Hlavní autoři: Ayton, Scott, Lei, Peng, Appukuttan, Ambili T., Renoir, Thibault, Foliaki, Simote, Chen, Feng, Adlard, Paul A., Hannan, Anthony J., Bush, Ashley I.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007468/
https://ncbi.nlm.nih.gov/pubmed/31520307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-019-00785-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky